CoChat

Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis

Open access

The DOI matches its Crossref record; 86 of the 90 references it cites were found in a registry or an index.

Abstract

Objective: To summarise the available evidence on the risk of myocarditis and/or pericarditis following mRNA COVID-19 vaccination, compared with the risk among unvaccinated individuals in the absence of COVID-19 infection. Design: Systematic review and meta-analysis. Data sources: Electronic databases (Medline, Embase, Web of Science and WHO Global Literature on Coronavirus Disease), preprint repositories (medRxiv and bioRxiv), reference lists and grey literature were searched from 1 December 2020 until 31 October 2022. Study selection: Epidemiological studies of individuals of any age who received at least one dose of an mRNA COVID-19 vaccine, reported a risk of myo/pericarditis and compared the risk of myo/pericarditis to individuals who did not receive any dose of an mRNA COVID-19 vaccine. Data extraction and synthesis: Two reviewers independently conducted screening and data extraction. The rate of myo/pericarditis among vaccinated and unvaccinated groups was recorded, and the rate ratios were calculated. Additionally, the total number of individuals, case ascertainment criteria, percentage of males and history of SARS-CoV-2 infection were extracted for each study. Meta-analysis was done using a random-effects model. Results: Seven studies met the inclusion criteria, of which six were included in the quantitative synthesis. Our meta-analysis indicates that within 30-day follow-up period, vaccinated individuals were twice as likely to develop myo/pericarditis in the absence of SARS-CoV-2 infection compared to unvaccinated individuals, with a rate ratio of 2.05 (95% CI 1.49–2.82). Conclusion: Although the absolute number of observed myo/pericarditis cases remains quite low, a higher risk was detected in those who received mRNA COVID-19 vaccinations compared with unvaccinated individuals in the absence of SARS-CoV-2 infection. Given the effectiveness of mRNA COVID-19 vaccines in preventing severe illnesses, hospitalisations and deaths, future research should focus on accurately determining the rates of myo/pericarditis linked to mRNA COVID-19 vaccines, understanding the biological mechanisms behind these rare cardiac events and identifying those most at risk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2022-065687

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow chart summarising the process to identify studies that met the eligibility criteria for inclusion in the systematic review.
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow chart summarising the process to identify studies that met the eligibility criteria for inclusion in the systematic review.CC BY-NC · PubMed Central
Figure 2 Meta-analysis of the rate ratios (RR) of myo/pericarditis in vaccinated relative to unvaccinated individuals. DL, DerSimonian-Laird.
Figure 2 Meta-analysis of the rate ratios (RR) of myo/pericarditis in vaccinated relative to unvaccinated individuals. DL, DerSimonian-Laird.CC BY-NC · PubMed Central
Figure 3 Rate ratio (RR) of myo/pericarditis in vaccinated relative to unvaccinated individuals by study setting. DL, DerSimonian-Laird.
Figure 3 Rate ratio (RR) of myo/pericarditis in vaccinated relative to unvaccinated individuals by study setting. DL, DerSimonian-Laird.CC BY-NC · PubMed Central
Figure 4 Rate ratio (RR) of myo/pericarditis in vaccinated relative to unvaccinated individuals within 30 days after vaccination and among concurrently unvaccinated comparators. DL, DerSimonian-Laird.
Figure 4 Rate ratio (RR) of myo/pericarditis in vaccinated relative to unvaccinated individuals within 30 days after vaccination and among concurrently unvaccinated comparators. DL, DerSimonian-Laird.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 86 references

Research works printed but not linked: 3

  1. StataCorp LLC . STATA meta-analysis reference manual release 17. Statistical Software. Texas, United States: Published by Stata Press, 2021.
  2. Office of Health Assessment and Translation (OHAT) . Handbook for Conducting a Literature-Based Health Assessment Using OHAT Approach for Systematic Review and Evidence Integration. 2019.
  3. Husby A , Hansen JV , Fosbøl E , et al . SARS-Cov-2 vaccination and myocarditis or Myopericarditis: population based cohort study. Bmj. BMJ 2021:e068665. doi:10.1136/bmj-2021-068665 · DOI · Paper page

Cited by

See all 45

Metadata

Authors
Alami, A., Krewski, D., Farhat, N., Mattison, D., Wilson, K., Gravel, C. A., Farrell, P. J., Crispo, J. A. G., Haddad, N., Perez-Lloret, S., & Villeneuve, P. J.
Affiliations
  • Carleton University (CA)
  • University of Ottawa (CA)
  • University of British Columbia (CA)
  • Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina
Corresponding author
Alami, Abdallah
Venue
BMJ Open
Publisher
BMJ
Published
2023-06
Volume
13
Issue
6
Pages
e065687
ISSN
2044-6055 (ISSN-L)
OpenAlex
W4381434687
Cited by
44
References
90
Citations by year
2026: 6 · 2025: 11 · 2024: 22 · 2023: 5
FWCI
2.30
Type
journal article
Language
en
Open access
Locations
  • BMJ Open (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
myocarditis, pericarditis, COVID-19 mRNA vaccine, vaccine safety, unvaccinated individuals, COVID-19 pandemic, adverse cardiac events, rate ratios
MeSH terms
COVID-19, SARS-CoV-2, COVID-19 Vaccines, Humans, Male, Myocarditis, Pericarditis, RNA, Messenger, Vaccination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1136/bmjopen-2022-065687
The paper
Alami, A., Krewski, D., Farhat, N., Mattison, D., Wilson, K., Gravel, C. A., Farrell, P. J., Crispo, J. A. G., Haddad, N., Perez-Lloret, S., & Villeneuve, P. J. (2023). Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis. BMJ Open. https://doi.org/10.1136/bmjopen-2022-065687

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.